She added, “these data articulate patient experience and further validate clinical research showing how austedo or austedo xr can help people living with tardive dyskinesia improve their symptoms while maintaining their mental health, something we care deeply about in our mission at teva to improve the lives of patients.” Austedo is a vmat2 inhibitor Here’s how it treats movement disorders. Td is a movement disorder that involves repetitive and uncontrollable body movements In fact, td can even develop after these medications are stopped, changed, or their dose is reduced Td is more than a side effect of these.
After 3 months on austedo or austedo xr, patients reported meaningful improvements in speech/communication (77% reported improvement), eating (75%), psychosocial impact (65%), activities of daily living (59%), and sleep/pain (50%) Data showed a mean decrease of 2.9 for the total motor score on the abnormal involuntary movement scale. Learn how quickly austedo works for treating tardive dyskinesia and huntington's chorea Clinical trials show initial improvements in as little as 2 weeks, with optimal results after dose titration Find out about austedo's onset and what to expect during treatment. Deutetrabenazine is used to treat movement disorders, including tardive dyskinesia and chorea caused by huntington's disease
This medicine is available only with your doctor's prescription. Austedo is a prescription medicine that is utilized to treat certain movement disorders caused by huntington’s disease and tardive dyskinesia It contains the active ingredient deutetrabenazine, which works by reducing the amount of certain chemicals in the brain that contribute to abnormal movements.
OPEN
